Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

Recs

0
Player Avatar mrindependent (34.35) Submitted: 7/19/2011 5:50:30 PM : Outperform Start Price: $38.65 JAZZ Score: +19.38

value screen

Featured Broker Partners


Advertisement